ArticleScience translational medicine2024

Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.

Jinchao Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.